Enforcement Trends: OIG Calls Out CMS for Not Preventing Medicare Genetic Testing Overpayments
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
From - National Intelligence Report
One patient claims it is and wants $1.8 million in damages because she never got it…
From - National Intelligence Report
Veteran OIG semiannual report aficionados will find little in the most recent edition to distinguish it markedly from its predecessors. But while a new…
From - National Intelligence Report
It has been nearly two years since Millennium went into Chapter 11 but the case continues to make news. After agreeing to…
From - National Intelligence Report
The CLIA standards that a lab must meet are based on the complexity of the in vitro diagnostic tests it…
From - National Intelligence Report
Case: Next Health is in a legal fight for its life. Earlier this year, the feds indicted two officials of the Dallas lab company for accepting $190,000 in bribes in exchange for…
From - National Intelligence Report
Last year at this time, the Justice Department announced the results of a nationwide takedown involving "the most defendants charged and largest alleged loss amount in…